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DOI: 10.1039/c0an00031kA microfluidic-based system was developed for the in situ monitoring of the 7-ethoxyresorufin
O-dealkylation (EROD) activity of primary rat hepatocytes by measuring the fluorescent intensity
of both cells and their surrounding media. The microfluidic chip was designed to allow the cell
suspension and test reagent to be introduced in a layer-by-layer flow format, thereby resulting in a short
mixing time by diffusion. A good linear relationship was obtained between the resorufin concentration
up to 30 mM and fluorescent intensity over the chip’s circular chamber area. The EROD activity was
determined with 3-methylcholanthrene (3-MC)-induced hepatocytes. The inhibition effect of
a-naphthoflavone was also examined on EROD activity resulting in an IC50 value of 12.98 mM.1. Introduction
Hepatic cytochrome P450 (CYP450) is a family of variant
enzymes that catalyses the oxidative metabolism of a wide variety
of exogenous chemicals including drugs, carcinogens, toxins and
endogenous compounds such as steroids, fatty acids and pros-
taglandins.1,2 The quantitative determination of CYP450 enzy-
matic activity in mammalian hepatocytes is a commonly used
method for drug screening and detecting general toxicity where
CYP activity can be induced or inhibited by specific test
compounds.3–5 One of the commonly used assays for CYP450
enzymatic activity is 7-ethoxyresorufin O-dealkylation (EROD),
which is based on the conversion of 7-ethoxyresorufin (7-ER)
to resorufin, a reaction catalysed by CYP4501A enzymes
(eqn (1)).6–8 Since the product is fluorescent, the kinetics of the
reaction can be quantified by the measurement of fluorescence
intensity during the reaction, which is directly related to
CYP4501A enzymatic activity.
(1)
The determination of EROD activity is typically carried out in
a multi-well (e.g., 96-well) plate using a fluorescence reader to
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tion on cell behaviour, function and genotype, based on the
average measurements of cell populations, it is incapable of
measuring the kinetics of enzyme reactions occurring within
individual cells. In the case of EROD process, it involves both
reaction (eqn (1)) and subsequent mass transport steps where
fluorescent resorufin produced transfers by diffusion across the
cell membrane towards the outside, and a closer examination of
the reaction step is important for understanding the enzymatic
reaction kinetics and mechanism. However, conventional
methods of cell observation are unable to distinguish between
these two steps.
In recent years, there has been an increasing awareness of the
importance of cell heterogeneity in clinical diagnostics, which has
been reflected in the shift from studying large cell populations
(to obtain average cell responses) to single cell measurements.9–11
The development of single cell-based analysis not only provides
complementary information on a cell population but can also
help reveal the actual functional interaction of biomolecules at
both a cellular and tissue level.12,10
Over the past two decades, significant developments in the field
of miniaturised systems, so-called microfluidics or lab-on-a-chip
technologies, have seen the methodology influence diverse areas
of applications relating to analytical chemistry, biochemistry,
clinical diagnosis, medical chemistry and industrial
chemistry.13,14 It has been demonstrated that such microsystems
represent advantages over conventional bench systems in terms
of speed, performance, reduced sample/solvent quantity, inte-
gration and automation. Of particular relevance to cell analysis is
the small length scale used in which fluidics are restricted to
diffusive mixing under laminar flow, thereby enabling precise
fluidic control to create a biomimetic cell microenvironment. The
microfluidic control also provides unique opportunities for
delivering and locating single cells within microchips with an
appropriate micro-geometry design. In addition, coupling with
microscope-based imaging techniques allows the detection and
measurement of single cell and subcellular levels in situ.15This journal is ª The Royal Society of Chemistry 2010
Consequently, a wide range of microfluidic-based methodologies
has been developed for cell manipulation, culture and analysis
including hepatocytes.4,16
The aim of this feasibility study is to develop a microfluidic-
based system that enables the in situ monitoring of EROD
activity using primary rat hepatocytes by measuring the fluo-
rescent intensity of both single cells and the surrounding media.
The inhibition of EROD activity will be examined using
a-naphthoflavone (a-NF) as a CYP1A inhibitor over a range of
concentrations (0–40 mM).2. Materials and methods
2.1. Microfluidic chip fabrication
The microfluidic device was produced according to published
procedures with minor adaptations.17,18 Briefly, the channel
network was fabricated using a photolithographic fabrication
method. The channel network was first designed using Auto-
CAD drawing software (Autodesk, Farnborough, UK). A film
negative of the desired fluidic network was then prepared by
a commercial photo mask manufacturer (J.D. Photo Tools,
Oldham, UK) to form the optical mask. B-270 glass photolith-
ographic plates (thickness of 3 mm) coated with a thin chromium
metal mask layer plus an upper layer of positive photoresist,
supplied by Telic (Telic Company, Valencia, USA), were used for
channel network fabrication. With UV exposure, the pattern of
interconnecting channels was transferred from the optical mask
to the photoresist layer, which was then developed and removed
together with the chromium layer to reveal the channel areas of
glass to be etched. The channels were etched using a mixture of
1% (w/w) HF and 5% (w/w) NH4F in water at 65
C.
The fabricated microchannel network consisted of a circular
chamber (for cell holding and monitoring) with two inlet chan-
nels and one outlet channel (Fig. 1a). To create two layers of
sheet flow in the main inlet channel and the chamber, the inlet
channels were etched separately on two glass plates, which were
then bonded face-to-face. Channels on each glass plate were
etched to a depth of 35 mm, resulting in a total depth of 70 mm for
the main channel and the chamber. The width for all the channels
was 150 mm, and the circular chamber had a diameter of 900 mm,
providing a working volume of 0.0445 ml. The main purpose of
using lay-by-layer sheet flow instead of side-by-side flow was to
reduce the diffusion distance in order to shorten the diffusive
mixing time whilst providing a relatively large field of view.Fig. 1 Schematic of chip design (a) and hepatocytes in suspension
loaded onto the chip in the circular chamber (b). Scale bar: 100 mm.
This journal is ª The Royal Society of Chemistry 2010Three holes (dia. 1.5 mm) were drilled through the upper glass
plate to link the ends of the channels with tubing. The upper plate
was then aligned with the channel geometry on the base plate and
thermally bonded by placing it in a muffle furnace set at 570 C
for 3 h. A 90 g block of stainless steel was placed onto the upper
plate to assist bonding.2.2. Cell culture and assay reagents
Preserved rat hepatocytes were supplied by Abcellute (Abcellute
Ltd, Cardiff, UK) and maintained at a temperature of 10 C
during transportation. Both 3-methylcholanthrene (3-MC)-
induced (72 h) hepatocytes and controls were supplied. The
preserved hepatocytes were then reactivated with the reactivation
medium and wash medium, which were supplied with the cells,
using the Abcellute protocol ABC-REC-S. The concentration of
cells used for loading the chip during the experiment was in the
range of 1  106 cells ml1. The viability of hepatocytes was
assessed prior to introduction on the chip using the trypan blue
exclusion method with a haemocytometer.
The buffer solution was prepared by adding one pot of KHB
(Krebs-Heinslett buffer) powder to 1 l of distilled water in
a volumetric flask supplemented by amikacin (84 mg ml1),
calcium chloride (1 mM), gentamicin (84 mg ml1), HEPES
(20 mM), heptanoic acid (4.2 mM) and sodium bicarbonate
(28.5 mM), and then adjusted to pH 7.4 with either 1 M NaOH
or 1 M HCl. Other chemicals were used as received, including
7-ER, resorufin, 3,30-methylenebis(4-hydroxycoumarin) (or
dicumarol), a-NF, acetonitrile and dimethyl sulfoxide (DMSO).
All these materials were supplied by Sigma-Aldrich (Dorset,
UK). To make the test reagent, dicumarol was first dissolved in
DMSO and then diluted, together with 7-ER, in buffer to the
desired concentration. The blank was DMSO only (at the
equivalent concentration) added to the buffer.2.3. Instrumentation and image analysis
An Axiovert S100 inverted microscope (Carl Zeiss, UK) using
both transmission and fluorescent optics coupled with a mono-
chrome CCD digital camera (C4742-95-12NRB, Hamamatsu
Photonics, UK) was used to obtain both conventional micro-
graphs and digital videos. AQM Hamamatsu ORCA I software
(Kinetic Imaging, Nottingham, UK) was used for image acqui-
sition and analysis. By selecting areas (e.g., cells or whole
chamber) in successive video images a light intensity profile
versus time was obtained. A Chroma green filter set (P/N 11002,
Chroma Technology Corp, Rockingham, USA) was selected,
which consists of an Exciter D546/10, an Emitter E590LP and
a beam splitter Dichroic 565DCLP.
Two KDS 200 syringe pumps (KD Scientific Inc., Holliston,
USA) were used to deliver cells in suspension and test reagents.
ETFE (ethylene tetrafluoroethylene) polymer tubing with an
inner diameter of 250 mm and outer diameter of 1/160 0 (P/N 1529),
on/off valves (P/N P-782) and appropriate fittings and connec-
tors, all obtained from Upchurch (Upchurch Scientific Inc., Oak
Harbor, USA), were used for plumbing to link the chip and
syringes.
To maintain the chip temperature during measurements,
a heated microscope stage (Model 14472, World PrecisionAnalyst, 2010, 135, 1282–1287 | 1283
Instruments Ltd, Stevenage, UK) with an aperture of 6 mm in
diameter was used and the temperature was controlled in the
range of 37  0.5 C. When the cells were loaded onto the chip,
the measurement of EROD activity was carried out by taking
a series of digital images as a video clip covering the whole
circular chamber area of the chip under the fluorescent condi-
tions. The scan rate of the video was set to be one frame every
two minutes with an exposure time of 20 ms. To minimise the
photo bleaching effect, a shutter was inserted into the light path
which was open (for 2 s) only when taking each image frame. All
fluorescent images were taken under the same conditions for
comparison and data analysis.Fig. 2 Fluorescent intensity of single cells (n ¼ 12) vs. time.3. Results and discussion
3.1. Cell loading
Hepatocytes in suspension and the test reagent were introduced
into the chip at a flow rate of 15 ml min1 via the two inlet
channels, in a continuous flow, layer-by-layer format (Fig. 1a).
The test reagent was composed of 40 mM 7-ER and 80 mM
dicumarol in buffer, where dicumarol was added to prevent the
disappearance of resorufin fluorescence since the product resor-
ufin (eqn (1)) can be further reduced through metabolism by
cytosolic oxidoreductases.7,19 Once a steady flow had been
established, the on/off valves on all three inlet and outlet tubes
were closed simultaneously,17 and the measurement process
started. Fig. 1b shows the hepatocytes retained in the chip
chamber in bright-field view after loading.
It can be seen from Fig. 1 that the delivery procedure allowed
hepatocytes to be distributed reasonably evenly on the bottom of
the chamber, whereas the test reagent solution was placed in the
top layer above the cell/media. When the flow was stopped and
all the valves were closed, cells in the chamber tended to settle
down and attach to the bottom surface within about 10 s, and
diffusive mixing occurred based on Fick’s law,20 which defines
the relationship between the distance travelled, d, by a molecule






where D is the diffusion coefficient. Using this equation, the time
needed for a resorufin molecule to diffuse across a distance of
70 mm, i.e., the chamber depth, is estimated to be 5.1 s, based on
the diffusion coefficient value of 4.801010 m2 s1 as determined
by Schilling et al.21Compared to the typical measurement time of
20 min this time for diffusion was not expected to cause signifi-
cant errors for kinetic measurements.
It was also observed that the hepatocytes were distributed as
an attached monolayer within the 70 mm deep chamber where the
size of the hepatocytes was in the range of 10–20 mm in diameter.
This monolayer distribution clearly simplified the process of
image analysis and made it possible to select either a single cell or
the surrounding media (outside the cell) for further analysis
based on the fluorescent intensity. In addition, the cell viability
assessment before and after passing through the chip without
reaction over a given time period was not significantly different
between the samples on the chip and in the batch micro-well
plate.1284 | Analyst, 2010, 135, 1282–12873.2. Single cell monitoring
Upon the reaction taking place an increase in fluorescent inten-
sity from the resorufin was observed for almost all hepatocytes.
Fig. 2 shows the plot of fluorescent intensity of 12 individual cells
randomly selected as a function of time (the fluorescent curves
have been normalised for comparison). It was found that the
fluorescent intensity for all cells showed a similar profile with
some variations; fluorescent intensity increased approximately
linearly for the first 10–12 min, reaching a maximum and then
followed by a relatively stable period (and a gradual decline for
some cells).
The fluorescent intensity of most cells (about nine out of 12)
fell in a standard deviation of 15% compared with the average.
This intensity difference was probably because of the variation in
cell size. By examining the cell morphology (Fig. 1b), it was
found that the cell size distribution for the majority of cells
(about 80%) was within the range of 20% compared with the
average, which corresponds closely to the maxima for the cells’
fluorescent intensities; the highest fluorescent intensity corre-
sponds to the largest cell size and the lowest fluorescent intensity
to the smallest cell size, although the variation in activity for
individual cells cannot be ruled out.
However, the variation in the time needed for each single cell
to reach the maximum fluorescence was indicative of alterations
in reaction rates among individual cells. This method, therefore,
can provide a useful tool for the measurement of the kinetics of
enzyme reactions occurring within individual cells. It was also
shown that the chip-based measurement required a remarkably
low number of cells, which can be a major advantage when
screening limited amounts of cell samples.22
3.3. In situ measurement of EROD activity
As discussed above, the measurement of EROD activity is based
on the conversion of 7-ER (which is delivered with the test
reagent) to fluorescent resorufin.23,24 This reaction was catalysed
by cytochrome CYP1A, the expression of which was induced by
3-MC. Since the biocatalytic conversion of 7-ER to resorufin
occurred inside hepatocytes, temporarily, the increase in fluo-
rescent intensity started within hepatocytes and was followed by
the fluorescent intensity increase in the surrounding media asThis journal is ª The Royal Society of Chemistry 2010
Fig. 4 Integrated fluorescent intensity from areas covering the cells,
media or whole circular chamber.resorufin diffused outside cells. Spatially, the accumulation of the
fluorescent intensity, both inside and outside hepatocytes,
represented the total amount of resorufin produced.
This process was detected, both temporarily and spatially, by
monitoring fluorescent intensity changes over the chip chamber
area while the reaction progressed with time. Fig. 3 shows two
example snapshots at reaction time zero and 10 min to compare
the fluorescent intensity changes in both cells and the
surrounding media. It can be seen clearly that at the beginning of
the reaction resorufin production started showing significant
fluorescence within the cells only (Fig. 3a). With the increase in
resorufin concentration inside the cells, resorufin diffusion across
the cell membrane towards the outside became more significant,
resulting in a bright fluorescence in the media within the whole
chamber (Fig. 3b).
Fig. 4 compares the integrated fluorescent intensities from
cells, the surrounding media and the whole circular chamber. It
was seen that the integrated fluorescent intensity of all cells was
just about 10% of that from the surrounding media, although the
cell area was generally brighter. To obtain the total amount of
the resorufin produced during the process, the fluorescent
intensity from the whole circular chamber area was used because
it represents the analyte in both cells and media, which could be
converted to a concentration-dependant calibration model.
To correlate the fluorescent intensity with the resorufin
concentrations within the chamber, a calibration method was
carried out in which the fluorescent intensity was measured over
the whole circular chamber area with a wide range of resorufin
concentrations. It was observed that the fluorescent intensity
gave a good linear relationship (Int ¼ 1.7554  Conc  0.0095)
with the resorufin concentration in the range of 0–30 mM (Fig. 5).
Above that concentration, the fluorescent intensity tended to be
lower than predicted, which was thought to be caused by the
saturation of the CCD detector. Since the working concentration
was normally in the range of a few mM the linear correlation was
considered suitable for determining the resorufin concentration
in this study. Using the calibration curve the resorufin concen-
tration profile was obtained. Fig. 5 shows a plot of the resorufin
concentration as a function of time. It can be seen that the
general trend followed the profile of the fluorescent intensity.
The blank result is also included for comparison, which indicated
no significant increase in fluorescent intensity.Fig. 3 Fluorescent intensity variations in both cells and media during
the reaction of EROD at time zero (a) and 10 min (b). Scale bar: 100 mm.
(A weak transmission light was applied for a better visibility of the
chamber and channel).
This journal is ª The Royal Society of Chemistry 20103.4. Inhibition of EROD activity
CYP1A enzymes are active in the biotransformation of both
endogenous substances and xenobiotics.25 They can activate
innocuous promutagens into their mutagenic and/or carcino-
genic forms through the production of highly reactive epoxide
intermediates that can bind potently to DNA and initiate carci-
nogenesis.26 Thus, the examination of the inhibition of CYP1A
enzymatic activity is important in the studies of toxicology and
drug metabolism, whereas hepatic microsomal EROD activity is
an indicator of CYP1A.27
In this study, the effect of a model CYP1A inhibitor a-NF was
examined on the 3-MC-induced rat hepatocytes when various
concentrations of a-NF were added to the test reagent for a range
of concentrations (0–40 mM). EROD activity was measured
using the procedure described above under identical fluidic
conditions, and the results are summarised in Fig. 6. It was found
that with higher inhibitor concentrations the corresponding
fluorescent intensity became lower, as expected. When the
concentration of a-NF reached 40 mM, no significant ERODFig. 5 Resorufin production as a function of time, and (inset) the cali-
bration of fluorescent intensity vs. resorufin concentration.
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Fig. 6 Resorufin production as a function of time with inhibitor a-NF at
different concentrations.activity was observed, which was comparable with the result of
the blank test. The relationship between the inhibition effect and
inhibitor a-NF concentration is plotted in Fig. 7, where the
inhibition effect is expressed as a percentage of the EROD
activity remaining.
In biochemical and biomedical studies for dose-response
relationships, a four-parameter logistic model has frequently
been used to obtain the IC50 value in drug testing (IC50 represents
the concentration of an inhibitor at which 50% of the maximal
response is observed).28,29 This model was employed for fitting
the experimental data shown in Fig. 6:
y ¼ AD
1þ ðx=CÞB þD (3)
where y is the EROD activity remaining as a percentage and x is
the inhibitor a-NF concentration (mM). A and D are the upper
and lower asymptotes, respectively. B is the slope of the curve
(or Hill slope) and C is the central point of the linear portion of
the curve, i.e., IC50. By fitting the experimental data to the four-
parameter logistic model, the best fit of the four parameters was
found to be 98.63, –2.27, 3.36 and 12.98, respectively.Fig. 7 Effects of various concentrations of inhibitor a-NF. The inhibi-
tion effect is expressed as percentage of EROD activity remaining.
1286 | Analyst, 2010, 135, 1282–12874. Conclusions
A microfluidic-based system was developed for the in situ
monitoring of EROD activity for primary rat hepatocytes by
measuring the fluorescent intensity of both single cells and their
surrounding media. The glass microfluidic chip enabled the cell
suspension and test reagent to be introduced in a layer-by-layer
flow format, thereby resulting in a short mixing time by diffu-
sion. A calibration showed a good linear relationship between
the resorufin concentration up to 30 mM and fluorescent inten-
sity. EROD activity was measured with 3-MC-induced hepato-
cytes, and the inhibition effect of a-NF was also examined on
EROD activity.Acknowledgements
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